Abeona Therapeutics: Q4 Earnings Snapshot
CLEVELAND (AP) — CLEVELAND (AP) — Abeona Therapeutics Inc. (ABEO) on Tuesday reported a loss of $20.5 million in its fourth quarter. On a per-share basis, the Cleveland-based company said it had a loss of 34 cents. The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 35 cents per share. The drug developer posted revenue of $5.4 million in the period, also topping Street forecasts. Four analysts surveyed by Zacks expected $5.1 million. The company’s shares closed at $4.95. A year ago, they were trading at $5.29. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ABEO at https://www.zacks.com/ap/ABEO